164 related articles for article (PubMed ID: 37627159)
1. Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer.
Lin HY; Yu CC; Chi CL; Wei CK; Yin WY; Tseng CE; Li SC
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627159
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine deiminase 2 plays a key role in osteogenesis by enhancing RUNX2 stability through citrullination.
Kim HJ; Shin HR; Yoon H; Park MS; Kim BG; Moon JI; Kim WJ; Park SG; Kim KT; Kim HN; Choi JY; Ryoo HM
Cell Death Dis; 2023 Aug; 14(8):576. PubMed ID: 37648716
[TBL] [Abstract][Full Text] [Related]
3. The Clinical and Prognostic Significance of Protein Arginine Deiminases 2 and 4 in Colorectal Cancer.
Gijon M; Metheringham RL; Toss MS; Paston SJ; Durrant LG
Pathobiology; 2022; 89(1):38-48. PubMed ID: 34569542
[TBL] [Abstract][Full Text] [Related]
4. Peptidylarginine deiminase 2 promotes T helper 17-like T cell activation and activated T cell-autonomous death (ACAD) through an endoplasmic reticulum stress and autophagy coupling mechanism.
Yang YF; Wang CM; Hsiao IH; Liu YL; Lin WH; Lin CL; Hung HC; Liu GY
Cell Mol Biol Lett; 2022 Mar; 27(1):19. PubMed ID: 35236296
[TBL] [Abstract][Full Text] [Related]
5. PADI2-Catalyzed MEK1 Citrullination Activates ERK1/2 and Promotes IGF2BP1-Mediated SOX2 mRNA Stability in Endometrial Cancer.
Xue T; Liu X; Zhang M; E Q; Liu S; Zou M; Li Y; Ma Z; Han Y; Thompson P; Zhang X
Adv Sci (Weinh); 2021 Mar; 8(6):2002831. PubMed ID: 33747724
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
Oncologist; 2012; 17(1):13. PubMed ID: 22210086
[TBL] [Abstract][Full Text] [Related]
7. PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling.
Wang H; Xu B; Zhang X; Zheng Y; Zhao Y; Chang X
Cancer Cell Int; 2016; 16():61. PubMed ID: 27478411
[TBL] [Abstract][Full Text] [Related]
8. Protein-arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination.
Funayama R; Taniguchi H; Mizuma M; Fujishima F; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Cancer Sci; 2017 Apr; 108(4):713-718. PubMed ID: 28403548
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
10. Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors.
Guo W; Zheng Y; Xu B; Ma F; Li C; Zhang X; Wang Y; Chang X
Onco Targets Ther; 2017; 10():1475-1485. PubMed ID: 28331341
[TBL] [Abstract][Full Text] [Related]
11. The Essential Role of Peptidylarginine Deiminases 2 for Cytokines Secretion, Apoptosis, and Cell Adhesion in Macrophage.
Yu HC; Tung CH; Huang KY; Huang HB; Lu MC
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785008
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
13. PADI2-Mediated Citrullination Promotes Prostate Cancer Progression.
Wang L; Song G; Zhang X; Feng T; Pan J; Chen W; Yang M; Bai X; Pang Y; Yu J; Han J; Han B
Cancer Res; 2017 Nov; 77(21):5755-5768. PubMed ID: 28819028
[TBL] [Abstract][Full Text] [Related]
14. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
McElwee JL; Mohanan S; Griffith OL; Breuer HC; Anguish LJ; Cherrington BD; Palmer AM; Howe LR; Subramanian V; Causey CP; Thompson PR; Gray JW; Coonrod SA
BMC Cancer; 2012 Oct; 12():500. PubMed ID: 23110523
[TBL] [Abstract][Full Text] [Related]
15. Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers.
Ogul A; Kidi MM; Buyuksimsek M
J Gastrointest Cancer; 2021 Mar; 52(1):294-299. PubMed ID: 32495108
[TBL] [Abstract][Full Text] [Related]
16. PADI2 is significantly associated with rheumatoid arthritis.
Chang X; Xia Y; Pan J; Meng Q; Zhao Y; Yan X
PLoS One; 2013; 8(12):e81259. PubMed ID: 24339914
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis.
Cantariño N; Musulén E; Valero V; Peinado MA; Perucho M; Moreno V; Forcales SV; Douet J; Buschbeck M
Mol Cancer Res; 2016 Sep; 14(9):841-8. PubMed ID: 27280713
[TBL] [Abstract][Full Text] [Related]
18. The expression of mRNA for peptidylarginine deiminase type 2 and type 4 in bone marrow CD34+ cells in rheumatoid arthritis.
Nagai T; Matsueda Y; Tomita T; Yoshikawa H; Hirohata S
Clin Exp Rheumatol; 2018; 36(2):248-253. PubMed ID: 29148420
[TBL] [Abstract][Full Text] [Related]
19. Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease.
Kim Y; Rebman AW; Johnson TP; Wang H; Yang T; Colantuoni C; Bhargava P; Levy M; Calabresi PA; Aucott JN; Soloski MJ; Darrah E
Front Neurol; 2022; 13():874211. PubMed ID: 35734473
[TBL] [Abstract][Full Text] [Related]
20. Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
Gao BS; Rong CS; Xu HM; Sun T; Hou J; Xu Y
Pathol Oncol Res; 2020 Apr; 26(2):1279-1285. PubMed ID: 31267364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
